Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Helen of Troy stock in Canada | $233.99
Own Helen of Troy shares in just a few minutes.
Helen of Troy is a household & personal products business based in the US. Helen of Troy stocks (HELE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $218.51 – a decrease of 0.17% over the previous week. Helen of Troy employs 1,769 staff and has a trailing 12-month revenue of around $2.2 billion.
How to buy Helen of Troy stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: HELE in this case.
- Research Helen of Troy stocks. The platform should provide the latest information available.
- Buy your Helen of Troy stocks. It's that simple.
Is it a good time to buy Helen of Troy stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Helen of Troy?
- Has coronavirus impacted Helen of Troy shares?
- Helen of Troy shares summary
- Compare share dealing platforms
- Is Helen of Troy stock a buy or sell?
- Helen of Troy performance over time
- Can I short Helen of Troy shares?
- Are Helen of Troy shares over-valued?
- Helen of Troy's financials
- How volatile are Helen of Troy shares?
- Does Helen of Troy pay a dividend?
- Have Helen of Troy shares ever split?
- Other common questions
How has Coronavirus impacted Helen of Troy's stock price?
Since the stock market crash in March caused by coronavirus, Helen of Troy's stock price has had significant positive movement.
Its last market close was $233.99, which is 19.39% up on its pre-crash value of $188.63 and 124.96% up on the lowest point reached during the March crash when the stocks fell as low as $104.015.
If you had bought $1,000 worth of Helen of Troy stocks at the start of February 2020, those stocks would have been worth $600.58 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,256.53.
Helen of Troy stock priceUse our graph to track the performance of HELE stocks over time.
Helen of Troy stocks at a glance
|Latest market close||$233.99|
|52-week range||$181.845 - $265.97|
|50-day moving average||$232.9685|
|200-day moving average||$223.2237|
|Wall St. target price||$248.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$10.025|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Helen of Troy price performance over time
|1 week (2021-09-09)||1.39%|
|1 month (2021-08-19)||1.97%|
|3 months (2021-06-18)||7.70%|
|6 months (2021-03-19)||11.80%|
|1 year (2020-09-18)||20.12%|
|2 years (2019-09-18)||51.91%|
|3 years (2018-09-18)||86.37%|
|5 years (2016-09-16)||173.99%|
Is Helen of Troy under- or over-valued?
Valuing Helen of Troy stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Helen of Troy's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Helen of Troy's P/E ratio
Helen of Troy's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Helen of Troy stocks trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stocks or simply that they're under-valued.
Helen of Troy's PEG ratio
Helen of Troy's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.8778. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Helen of Troy's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Helen of Troy's EBITDA
Helen of Troy's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$333.6 million.
The EBITDA is a measure of a Helen of Troy's overall financial performance and is widely used to measure a its profitability.
Helen of Troy financials
|Revenue TTM||USD$2.2 billion|
|Operating margin TTM||13.35%|
|Gross profit TTM||USD$927.3 million|
|Return on assets TTM||8.57%|
|Return on equity TTM||20.68%|
|Market capitalisation||USD$5.6 billion|
TTM: trailing 12 months
How to short and sell Helen of Troy stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "HELE.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 2.3 million Helen of Troy stocks held short by investors – that's known as Helen of Troy's "short interest". This figure is 0.2% down from 2.3 million last month.
There are a few different ways that this level of interest in shorting Helen of Troy stocks can be evaluated.
Helen of Troy's "short interest ratio" (SIR)
Helen of Troy's "short interest ratio" (SIR) is the quantity of Helen of Troy stocks currently shorted divided by the average quantity of Helen of Troy stocks traded daily (recently around 90733.162863887). Helen of Troy's SIR currently stands at 25.42. In other words for every 100,000 Helen of Troy stocks traded daily on the market, roughly 25420 stocks are currently held short.
However Helen of Troy's short interest can also be evaluated against the total number of Helen of Troy stocks, or, against the total number of tradable Helen of Troy stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Helen of Troy's short interest could be expressed as 0.1% of the outstanding stocks (for every 100,000 Helen of Troy stocks in existence, roughly 100 stocks are currently held short) or 0.0966% of the tradable stocks (for every 100,000 tradable Helen of Troy stocks, roughly 97 stocks are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the stock price, with a discouraging number of investors currently willing to bet against Helen of Troy.
Find out more about how you can short Helen of Troy stock.
Helen of Troy stock dividends
We're not expecting Helen of Troy to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Helen of Troy stocks ever split?
Helen of Troy stocks were split on a 2:1 basis on 23 September 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Helen of Troy stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Helen of Troy stocks which in turn could have impacted Helen of Troy's stock price.
Helen of Troy stock price volatility
Over the last 12 months, Helen of Troy's stocks have ranged in value from as little as $181.845 up to $265.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Helen of Troy's is 0.8455. This would suggest that Helen of Troy's stocks are less volatile than average (for this exchange).
Helen of Troy overview
Helen of Troy Limited designs, develops, imports, markets, and distributes a portfolio of consumer products worldwide. The company operates in three segments: Housewares, Health & Home, and Beauty. The Housewares segment offers food and beverage preparation tools and gadgets, storage containers, and organization products; coffee makers, grinders, manual pour overs, and tea kettles; household cleaning products, shower organization, and bathroom accessories; feeding and drinking products, child seating products, cleaning tools, and nursery accessories; and insulated water bottles, jugs, thermoses, drinkware, travel mugs, and food containers and accessories. The Health & Home segment provides thermometers, blood pressure monitors, and humidifiers; faucet mount water-filtration systems and pitcher based water filtration systems; and air purifiers, heaters, fans, and humidifiers. The Beauty segment provides hair, facial, and skin care appliances, as well as grooming brushes, tools, and decorative hair accessories; and liquid hair styling, treatment and conditioning products, shampoos, and skin care products. The company sells its products through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, grocery and specialty stores, beauty supply and e-commerce retailers, wholesalers, and various types of distributors, as well as directly to consumers under the OXO, Good Grips, Hydro Flask, Soft Works, OXO tot, OXO Brew, PUR, Honeywell, Braun, Vicks, Drybar, Hot Tools, Brut, Pert, Sure, Infusium, Revlon, and Bed Head brands. Helen of Troy Limited was incorporated in 1968 and is headquartered in El Paso, Texas.
Helen of Troy in the news
Helen of Troy Limited's (NASDAQ:HELE) Stock Been Rising: Are Strong Financials Guiding The Market?
Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal Year 2022 Results
Boston Trust Walden Small Cap Fund Buys Helen Of Troy, Columbia Banking System Inc, Chemed Corp, Sells , Williams-Sonoma Inc, Bruker Corp
Frequently asked questions
More on investing
Everything we know about the Tekla Healthcare Investors IPO, plus information on how to buy in. Read more…
We look at 6 popular stock discussion groups from Canada and overseas.Read more…
We’ve rounded up the top dividend stocks in Canada. Check out current stock prices, historical stock performance, company info and more.Read more…
More guides on Finder
How to buy Planet Labs (PL) stock in Canada when it goes public
Everything we know about the Planet Labs IPO, plus information on how to buy in.
How to buy Impossible Foods stock in Canada when it goes public
Everything we know about the Impossible Foods IPO, plus information on how to buy in.
How to buy Samsara stock in Canada when it goes public
Everything we know about the Samsara IPO, plus information on how to buy in.
How to buy Allbirds (BIRD) stock in Canada when it goes public
Everything we know about the Allbirds IPO, plus information on how to buy in.
How to buy Smooth Love Potion (SLP) in Canada
This guide will show you step-by-step instructions on how to buy the Smooth Love Potion (SLP) token as well as a list of exchanges you can trade it on.
How to buy OnlyFans stock in Canada when it goes public
Everything we know about the OnlyFans IPO, plus information on how to buy in.
How to buy Vinco Ventures stock in Canada | $7.77
Ever wondered how to buy shares in Vinco Ventures? We explain how and compare a range of providers that can give you access to many brands, including Vinco Ventures.
How to buy Weber stock in Canada | $14.99
Steps to owning and managing Weber Inc. stocks, with 24-hour and historical pricing before you buy.
How to buy Chobani stock in Canada when it goes public
Everything we know about the Chobani IPO, plus information on how to buy in.
How to buy Quickswap (QUICK) in Canada
This guide will show you step-by-step instructions on how to buy the Quickswap (QUICK) token as well as a list of exchanges you can trade it on.
Ask an Expert
You must be logged in to post a comment.